I-131-CLR 131

131I-CLR 131 (131I-CLR-1404, 131I-NM404) is a small molecule, an alkyl [...]

I-131-Apamistamab (Iomab-B™)

131I-Apamistamab (131I-BC8, Iomab-B™) is an anti-CD45 radioimmunotherapy for the [...]

Re-188-Etidronate (HEDP)

188Re-Etidronate (188Re-HEDP) is a therapeutic agent for bone metastases treatment. [...]

Lu-177-DOTAZOL

177Lu-DOTAZOL is a drug suitable for betatherapy of bone metastases [...]

Lu-177-TLX591

177Lu-TLX591 (177Lu-Rosopatamab, 177Lu-J591, 177Lu-ATL-101) is the Lutetium-177 labeled J591 [...]

Lu-177-ST2210 (IART – Lu-177 DOTA-Biotin)

IART® stands for Intraoperative Avidination for Radionuclide Treatment. It is [...]

Lu-177-PSMA-617 (Pluvicto™)

177Lu-PSMA-617 (177Lu-Vipivotide tetratexan) is a 177Lu labeled peptide developed [...]

Lu-177-Pentixather

177Lu-Pentixather is the therapeutic analogue of 68Ga-Pentixafor, to be used [...]

Lu-177-IPN-1072 (Lu-177-OPS201 – Lu-177-Satoreotide)

177Lu-IPN-1072 (177Lu-OPS201, 177Lu-DOTA-JR11, 177Lu-Satoreotide tetratexan) is the lutetium-177 analogue [...]

Lu-177-MVT-1075

177Lu-MVT-1075 is the therapeutic counterpart of 89Zr-DFO-HuMab-5B1 developed for the [...]

Go to Top